The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125586781 12558678 1 I 2014 20150828 20160715 20160715 PER US-ZYDUS-008973 ZYDUS PHARM 70.55 YR E F Y 0.00000 20160715 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125586781 12558678 1 PS WARFARIN WARFARIN 1 Oral UNKNOWN 40663 6 MG TABLET
125586781 12558678 2 SS WARFARIN WARFARIN 1 Oral U UNKNOWN 0 TABLET
125586781 12558678 3 SS WARFARIN WARFARIN 1 Oral UNKNOWN 0 20 MG TABLET
125586781 12558678 4 SS CLOPIDOGREL CLOPIDOGREL BISULFATE 1 Oral UNKNOWN 0 75 MG TABLET QD
125586781 12558678 5 C METOPROLOL. METOPROLOL 1 0 200 MG QD
125586781 12558678 6 C HYDROCHLOROTHIAZIDE/VALSARTAN 2 0 TABLET QD
125586781 12558678 7 C MONTELUKAST/MONTELUKAST SODIUM 2 0 10 MG TABLET QD
125586781 12558678 8 C FLUTICASONE PROPIONATESALMETEROL XINAFOATE FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 0 QD
125586781 12558678 9 C HYDROXOCOBALAMIN HYDROXOCOBALAMIN 1 0 SUBLINGUAL TABLET
125586781 12558678 10 C CICLOSPORIN CYCLOSPORINE 1 0
125586781 12558678 11 C VITAMIN D CHOLECALCIFEROL 1 U 0
125586781 12558678 12 C DENOSUMAB DENOSUMAB 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125586781 12558678 1 Atrial fibrillation
125586781 12558678 2 Atrial fibrillation
125586781 12558678 3 Atrial fibrillation
125586781 12558678 4 Atrial fibrillation
125586781 12558678 5 Hypertension
125586781 12558678 6 Hypertension
125586781 12558678 7 Chronic obstructive pulmonary disease
125586781 12558678 8 Chronic obstructive pulmonary disease
125586781 12558678 9 Supplementation therapy
125586781 12558678 10 Sjogren's syndrome
125586781 12558678 11 Osteoporosis
125586781 12558678 12 Osteoporosis

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125586781 12558678 Bleeding time prolonged Bleeding time prolonged
125586781 12558678 Contusion Contusion
125586781 12558678 Insomnia Insomnia
125586781 12558678 Muscle spasms Muscle spasms
125586781 12558678 Pain in extremity Pain in extremity

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125586781 12558678 1 2015 0
125586781 12558678 2 2014 2015 0
125586781 12558678 3 2015 0
125586781 12558678 4 2015 0